Mark T. Reding, MD, is Director of the Center for Bleeding and Clotting Disorders at University of Minnesota Medical Center in Minneapolis. In this role he is responsible for providing and coordinating patient care in the clinic and hospital for all adult patients followed by the Center, which is a federally funded Hemophilia Treatment Center. In addition, he is Associate Professor of Medicine in the Division of Hematology, Oncology, and Transplantation at the University of Minnesota.

Dr. Reding received his Bachelor of Science degree in microbiology and biology at South Dakota State University in Brookings. He then earned a Doctor of Medicine degree at University of Minnesota Medical School in Minneapolis, where he also completed internal medicine residency and a fellowship in hematology/oncology. He is board certified in hematology.

Dr. Reding’s clinical interest is the treatment of non-malignant blood diseases with particular emphasis on disorders of hemostasis and thrombosis, including hemophilia. He has served as the local principal investigator for multicenter clinical trials. His research has been published in peer-reviewed journals. Dr. Reding considers teaching to be the most important and rewarding aspect of his work, and he twice was awarded the Outstanding Clinical Mentor Award from his division at the Medical School. In addition to teaching responsibilities at the University, he frequently speaks at educational programs for physicians and other health care professionals. Dr. Reding is a member of American Society of Hematology, Hemostasis and Thrombosis Research Society (HTRS) and International Society for Thrombosis and Hemostasis.